Cargando…
Monomeric IgA Antagonizes IgG-Mediated Enhancement of DENV Infection
Dengue virus (DENV) is a prevalent human pathogen, infecting approximately 400 million individuals per year and causing symptomatic disease in approximately 100 million. A distinct feature of dengue is the increased risk for severe disease in some individuals with preexisting DENV-specific immunity....
Autores principales: | Wegman, Adam D., Fang, Hengsheng, Rothman, Alan L., Thomas, Stephen J., Endy, Timothy P., McCracken, Michael K., Currier, Jeffrey R., Friberg, Heather, Gromowski, Gregory D., Waickman, Adam T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654368/ https://www.ncbi.nlm.nih.gov/pubmed/34899736 http://dx.doi.org/10.3389/fimmu.2021.777672 |
Ejemplares similares
-
DENV-specific IgA contributes protective and non-pathologic function during antibody-dependent enhancement of DENV infection
por: Wegman, Adam D., et al.
Publicado: (2023) -
Temporally integrated single cell RNA sequencing analysis of PBMC from experimental and natural primary human DENV-1 infections
por: Waickman, Adam T., et al.
Publicado: (2021) -
Persistent COVID-19 Symptoms Minimally Impact the Development of SARS-CoV-2-Specific T Cell Immunity
por: Fang, Hengsheng, et al.
Publicado: (2021) -
Mechanism of neutralization of influenza virus by secretory IgA is different from that of monomeric IgA or IgG
Publicado: (1985) -
Transcriptional and clonal characterization of B cell plasmablast diversity following primary and secondary natural DENV infection
por: Waickman, Adam T., et al.
Publicado: (2020)